Metformin

A biguanide antidiabetic that lowers blood glucose by reducing hepatic glucose production and improving insulin sensitivity.

Metformin is the first-line oral agent for type 2 diabetes. It does not stimulate insulin secretion so hypoglycemia is rare when used as monotherapy. A common side effect is GI upset — take with food.

(Placeholder study content — expanded in the content build step.)

Related terms

Back to Pharmacological and Parenteral Therapies